2024. Modification and Characterization of Some New Levofloxacin Heterocyclic Derivatives as COX-2 Enzyme Inhibitors and Evaluate Their Efficacy Pharmacokinetics by Molecular Docking and the Swiss ADME Studies. Baghdad Science Journal. 21, 4 (Apr. 2024), 1255. DOI:https://doi.org/10.21123/bsj.2023.8295.